Sato, Masayo http://orcid.org/0000-0002-6107-9731
Tsujimoto, Mika
Kajimoto, Kenta
Uetake, Hideyuki
Shimoda, Hiroo
Fujiwara, Saeko
Article History
Received: 21 December 2017
Accepted: 19 June 2018
First Online: 5 July 2018
Compliance with ethical standards
: Patients gave written consent before enrollment and could withdraw from the study at any time without consequence. The study was conducted in accordance with the Japanese guideline for Good Post-marketing Study Practice (by the Ministry of Health, Labor and Welfare Ordinance No. 171; 20 Dec. 2004) and applicable laws and regulations.
: SF has served on speakers’ bureaus for Pfizer Japan Inc., Amgen Astellas BioPharma KK, Asahi Kasei Pharma Corp., and Alere Medical Co., Ltd. MS, MT, and KK are employees of Eli Lilly Japan K.K. HU and HS are employees of CMIC Co., Ltd., which was contracted by Eli Lilly Japan K.K. to conduct the statistical analysis.